Skip to main content

Table 4 Distribution of C1858T, A49G, and C(−318)T genotypes in the study group and control group

From: Association between genetic mutations and the development of autoimmune thyroiditis in patients with chronic hepatitis C treated with interferon alpha

SNP Genotypes Study group (n=101) Control group (n=200)
C1858T CC 74 (73.2%) 147 (73.5%)
  CT 25 (24.8%) 50 (25.0%)
  TT 2 (2.0%) 3 (1.5%)
  p=0.95347
A49G AA 43 (42.6%) 81 (40.5%)
  AG 58 (57.4%) 105 (52.5%)
  GG 0 (0.0%) 14 (7.0%)
  p=0.02423
C(−318)T CC 79 (78.2%) 151 (75.5%)
  CT 20 (19.8%) 48 (24.0%)
  TT 2 (1.98%) 1 (0.5%)
  p=0.35636